UFP Technologies Finds Replacement for its Retiring General Counsel
UFP Technologies Inc. has appointed Ryan Stafford as general counsel and senior vice president of Human Resources, succeeding the retiring Chris Litterio. Stafford brings nearly three decades of experience in legal and human resources leadership at publicly traded companies, with a strong background in M&A and organizational development. His appointment aligns with UFP Technologies' growth strategy, particularly in strategic acquisitions and scaling the business.
UFP Technologies (UFPT) Director Symeria Hudson Sells 298 Shares
UFP Technologies (UFPT) Director Symeria Hudson sold 298 shares of the company on August 18, 2026, totaling approximately $95,095. This sale contributes to a year-long trend of insider selling at UFPT, with no insider buys recorded against 11 insider sells. Despite the insider selling, some institutional investors ("gurus") tracked by GuruFocus are adding to their positions, presenting a mixed signal for investors as the stock is considered modestly overvalued based on its GF Value.
UFP Technologies (NASDAQ: UFPT) director sells 298 shares
UFP Technologies director Symeria Hudson sold 298 shares of the company's common stock on August 18, 2026, at a price of $319.11 per share. Following this transaction, Hudson directly holds 927 shares of UFPT common stock. This transaction is classified as an open-market sale and was not conducted under a Rule 10b5-1 trading plan.
UFP Technologies (NASDAQ:UFPT) Director Symeria Hudson Sells 298 Shares of Stock
UFP Technologies Director Symeria Hudson sold 298 shares of UFPT stock for $95,094.78 on August 18th, reducing her stake by 24.33%. This follows another sale of 1,926 shares four days prior. The company's stock rose 2.1% to $320.45, nearing its 52-week high, after beating quarterly earnings and revenue estimates.
Diversify Advisory Services LLC Buys Shares of 10,009 UFP Technologies, Inc. $UFPT
Diversify Advisory Services LLC acquired 10,009 shares of UFP Technologies, Inc. (NASDAQ:UFPT) valued at approximately $2.49 million during the second quarter. Despite insider selling totaling $6.23 million over the past 90 days and an overall "Hold" rating from analysts, UFP Technologies exceeded quarterly earnings and revenue expectations. The company reported EPS of $2.92 against an estimate of $2.31 and revenue of $173.96 million compared to an expected $159.38 million.
Ufp Technologies director sells $324,260 in stock
Cynthia L. Feldmann, a director at UFP Technologies Inc. (NASDAQ:UFPT), sold 1,000 shares of the company’s common stock for $324,260 on August 13, 2026. This transaction leaves Ms. Feldmann directly holding 4,476 shares. The sale occurred as UFP Technologies' shares trade near their 52-week high, despite InvestingPro indicating the stock is overvalued.
UFP Technologies director Symeria Hudson sells $625k in stock
Symeria Hudson, a director at UFP Technologies Inc, sold 1,926 shares of the company's common stock for over $625,000 on August 14, 2026, after exercising stock options the previous day. Following these transactions, Hudson directly holds 1,225 shares. The sale comes after strong year-to-date returns for the stock and recent impressive second-quarter 2026 results where the company beat analyst expectations for both earnings and revenue.
How Stronger 2026 Sales and Earnings Will Impact UFP Technologies (UFPT) Investors
UFP Technologies (UFPT) reported stronger sales and earnings in Q2 2026, with net income of US$20.85 million, supporting its investment narrative as a specialized supplier to medical device leaders. The company's future projections include $741.6 million revenue and $102.0 million earnings by 2029, implying a 10% upside to its current price based on fair value estimates. However, the company faces concentration risk due to its dependence on a few large customers like Intuitive Surgical and Stryker.
Ufp Technologies director sells $324,260 in stock
Cynthia L. Feldmann, a director at UFP Technologies Inc. (NASDAQ:UFPT), sold 1,000 shares of the company's common stock for $324,260 on August 13, 2026, holding 4,476 shares afterward. This sale occurred as UFPT shares approached a 52-week high, following strong year-to-date and past-year returns. The company recently reported impressive second-quarter 2026 financial results, surpassing analyst expectations for both adjusted earnings and revenue.
Rice Hall James & Associates LLC Takes $9.02 Million Position in UFP Technologies, Inc. $UFPT
Rice Hall James & Associates LLC has acquired a new position of 34,034 shares, valued at $9.02 million, in UFP Technologies, Inc. (NASDAQ:UFPT) during the second quarter. This move, along with investments from other institutions, has raised institutional ownership to 87.28%. Despite company insiders selling shares totaling $6.23 million, UFP Technologies reported strong quarterly earnings, beating revenue and EPS estimates, and analysts currently hold a consensus "Hold" rating on the stock.
Insider Selling: UFP Technologies (NASDAQ:UFPT) Director Sells $625,141.08 in Stock
UFP Technologies
Ufp Technologies Director Sold Shares Worth Over $625K
Hudson Symeria, a Director at Ufp Technologies, sold common stock on August 14, 2026, totaling $625,141. The shares were sold at a weighted average price of $324.58, with prices ranging from $324.36 to $324.945. Following this transaction, Symeria directly owns 1,225 shares of Ufp Technologies common stock.
UFP Technologies (UFPT) director sells 1,926 shares
UFP Technologies director Symeria Hudson reported exercising stock options for 1,196 shares and subsequently selling 1,926 common shares of UFPT. The option exercises took place on August 13, 2026, while the sale occurred on August 14, 2026, at a weighted average price of $324.58 per share. These transactions were not executed under a Rule 10b5-1 trading plan.
UFP Technologies (UFPT) director trims stake with 1,000-share sale
UFP Technologies (UFPT) director Cynthia L. Feldmann sold 1,000 shares of common stock on August 13, 2026, at a price of $324.26 per share in an open market transaction. Following this sale, Feldmann directly holds 4,476 shares of UFPT common stock. The transaction was classified as a non-derivative sale and was not made under a Rule 10b5-1 trading plan.
How Stronger 2026 Sales and Earnings Will Impact UFP Technologies (UFPT) Investors
UFP Technologies (UFPT) reported strong Q2 and H1 2026 results with increased sales and net income, reinforcing its investment narrative as a specialized supplier to medical device companies. The company's future outlook projects significant revenue and earnings growth by 2029, leading to a fair value estimate that suggests an upside to its current price. However, investors are cautioned about the concentration risk due to dependence on a few large customers.
UFP Technologies VP Jason Holt sells $348,700 in company stock
Jason Holt, Vice President at UFP Technologies Inc., recently sold 1,100 shares of company stock for $348,700. This sale occurred while the stock is near its 52-week high, having gained significantly year-to-date. The company also reported strong Q2 2026 financial results, surpassing analyst expectations for both earnings and revenue.
Diamond Hill Capital Management LLC Investment Advisor Invests $14.63 Million in UFP Technologies, Inc. $UFPT
Diamond Hill Capital Management LLC Investment Advisor recently acquired a new stake of 55,176 shares, valued at approximately $14.63 million, in UFP Technologies, Inc. This investment makes Diamond Hill Capital Management LLC Investment Advisor a significant institutional holder, owning about 0.71% of the company's stock. The article also details other institutional investment changes, UFP Technologies' price performance, recent earnings beat, analyst upgrades, and insider trading activity.
Maridea Wealth Management LLC Makes New Investment in UFP Technologies, Inc. $UFPT
Maridea Wealth Management LLC recently acquired a new stake in UFP Technologies, Inc. (NASDAQ:UFPT) by purchasing 7,901 shares valued at approximately $2.1 million. This investment highlights continued institutional interest in UFP Technologies, which has also seen other firms adjust their holdings. The company has demonstrated strong financial performance, exceeding quarterly earnings and revenue estimates, though insider selling has also occurred.
UFP Technologies executive chairman Bailly sells $4.1m in shares
R. Jeffrey Bailly, Executive Chairman of UFP Technologies Inc. (NASDAQ:UFPT), sold 13,011 shares of the company's common stock for a total of $4,113,220 on August 10, 2026. The sales were conducted in three separate transactions at weighted average prices between $315.53 and $317.27 per share. Following these transactions, Mr. Bailly's indirect and direct holdings in UFP Technologies common stock total 178,814 shares.
UFP Technologies (NASDAQ: UFPT) insider plans sale of 2,349 shares
UFP Technologies (NASDAQ: UFPT) has filed a Form 144 to register the planned sale of 2,349 shares of common stock through Merrill Lynch on or after August 14, 2026. The shares have an aggregate market value of $625,145.67 and represent a small fraction of the 7,745,790 shares outstanding. This sale is related to equity compensation and option activity from various dates between 2023 and 2026.
UFP Technologies (UFPT) insider files Form 144 to sell 1,000 shares
An insider at UFP Technologies (UFPT) has filed a Form 144 to sell 1,000 shares of common stock through Merrill Lynch, with an anticipated sale date of August 13, 2026, on NASDAQ. The filing indicates the seller previously received stock awards for compensation in 2023, 2024, and 2025, and had already sold 1,200 shares on June 12, 2026. This action is categorized with a neutral filing impact and sentiment.
Avoiding Lag: Real-Time Signals in (UFPT) Movement
The article analyzes Ufp Technologies Inc. (NASDAQ: UFPT), indicating a near-term neutral sentiment but mid and long-term strength. It highlights compelling upside potential with no resistance levels above the current price. The analysis includes AI-generated institutional trading strategies for position trading, momentum breakouts, and risk hedging, along with multi-timeframe signal analysis.
UFP Technologies Director Joseph John Hassett Files Corrected Beneficial Ownership Amendment
UFP Technologies Director Joseph John Hassett has filed an amended statement of beneficial ownership to correct an administrative error in a previous filing. The amendment updates his beneficial ownership from 2,425 to 2,602 shares of Common Stock. This correction relates to a transaction on June 4, 2026, with the amendment submitted on August 12, 2026.
UFP Technologies (UFPT) director amends Form 4 to correct 2,602-share holding
UFP Technologies director Joseph John Hassett has filed an amended Form 4 to correct an administrative error in his previously reported share holdings. The amendment clarifies that his correct beneficial ownership of Common Stock, $.01 Par Value, following a reported transaction was 2,602 shares, not the 2,425 shares originally stated. This filing does not involve a new transaction but solely rectifies the beneficial ownership amount.
Wasatch Advisors LP Sells 94,051 Shares of UFP Technologies, Inc. $UFPT
Wasatch Advisors LP reduced its stake in UFP Technologies (NASDAQ:UFPT) by 12.1% in the second quarter, selling 94,051 shares. Despite the sale, the firm still holds 683,262 shares valued at approximately $181.2 million, representing an 8.83% ownership. Institutional investors own a significant portion of UFPT, and company insiders have also sold shares recently, while the company reported strong quarterly earnings and analysts maintain a "Hold" rating.
The Top 5 Analyst Questions From UFP Technologies’s Q2 Earnings Call
UFP Technologies (UFPT) reported strong Q2 CY2026 results, exceeding revenue and profit expectations across its MedTech platform, driven by growth in cardiovascular, infection control, and orthopedics. CEO Mitchell Rock highlighted the company's diversified growth not tied to any single customer or product, with investments in capacity beginning to yield benefits. Analysts inquired about submarket strength, SG&A sustainability, acquisition pipeline, backlog resolution at AJR, and growth outside top customers.
r. Jeffrey Bailly, UFP Technologies executive chairman, sells $5m By Investing.com
R. Jeffrey Bailly, Executive Chairman of UFP Technologies Inc. (NASDAQ:UFPT), sold approximately $4.997 million worth of shares in early August 2026. The transactions involved 15,695 shares sold at prices ranging from $315.06 to $320.05. Despite these insider sales, UFP Technologies recently reported strong Q2 2026 financial results, exceeding Wall Street expectations in both earnings per share and revenue.
UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring the 9.23% Potential Upside in the Booming Medical Devices Sector
UFP Technologies, Inc. (UFPT) is presented as an appealing investment opportunity in the medical devices sector, boasting a $2.52 billion market cap and strong revenue growth of 15.10%. The company specializes in designing and manufacturing solutions for various medical devices, including advanced wound care and infection prevention. Analysts are cautiously optimistic with a consensus target price suggesting a potential upside of 9.23%, making UFPT a strong candidate for growth-focused portfolios due to its innovative products and robust operational performance.
UFP Technologies (UFPT) Executive Chairman reports trust sale of 13,011 shares
UFP Technologies Executive Chairman Jeffrey R. Bailly reported the indirect sale of 13,011 shares of Common Stock from a trust on August 10, 2026. The sales occurred in multiple open-market transactions at weighted average prices ranging from $315.53 to $317.27 per share, totaling approximately $4.11 million. Bailly disclaims beneficial ownership of the trust-held shares except for any pecuniary interest, and he still holds 171,200 shares directly.
UFP Technologies(UFPT.US) Officer Sells US$5 Million in Common Stock
The article reports that an officer at UFP Technologies (UFPT.US) sold common stock worth US$5 million. This transaction indicates a significant insider sale at the company.
UFP Technologies Executive Chairman Sold $5.00M In Company Stock
UFP Technologies Executive Chairman R. Jeffrey Bailly sold 15,695 shares of company stock for a total transaction value of $4,997,050. This insider transaction comes as UFPT shares are trading at $323.4, down 1.12%. The article also provides an overview of UFP Technologies's financial health, including revenue growth, profitability metrics, and financial valuation ratios.
The Top 5 Analyst Questions From UFP Technologies’s Q2 Earnings Call
UFP Technologies (UFPT) exceeded Wall Street's expectations in Q2 CY2026, driven by strong growth in its MedTech platform, particularly in cardiovascular, infection control, and orthopedics. CEO Mitchell Rock highlighted the company's diversified growth not tied to any single customer, while CFO Ronald Lataille addressed SG&A sustainability. Analysts inquired about submarket strength, acquisition strategy, backlog resolution, and new program ramp-ups, with management providing positive outlooks and detailing investment progress.
r. Jeffrey Bailly, UFP Technologies executive chairman, sells $5m
R. Jeffrey Bailly, Executive Chairman of UFP Technologies Inc. (NASDAQ:UFPT), sold nearly $5 million worth of company shares on August 6 and 7, 2026. The sales involved 15,695 shares at prices ranging from $315.06 to $320.05 per share. This insider sale occurs as UFPT trades near its 52-week high, with the stock showing a 52% return over the past year and an InvestingPro analysis suggesting it is overvalued.
r. Jeffrey Bailly, UFP Technologies executive chairman, sells $5m
R. Jeffrey Bailly, Executive Chairman of UFP Technologies Inc. (NASDAQ:UFPT), recently sold approximately $4.997 million worth of company shares in early August. These transactions occurred on August 6 and 7, 2026, involving 15,695 shares sold at prices between $315.06 and $320.05 per share. The sales happened as UFP Technologies trades near its 52-week high and follows robust second-quarter 2026 financial results, which surpassed Wall Street expectations.
UFP Technologies (UFPT) chair-linked trust sells 15,695 shares near $318–$320
Jeffrey R. Bailly, Executive Chairman of UFP Technologies (UFPT), reported the sale of 15,695 shares of common stock on August 6-7, 2026, through indirect holdings in a trust. The sales occurred at weighted-average prices ranging from approximately $315.06 to $320.05 per share. After these transactions, Bailly still directly holds 171,200 shares of UFPT.
R Jeffrey Bailly Sells 10,682 Shares of UFP Technologies (NASDAQ:UFPT) Stock
R. Jeffrey Bailly, Chairman of UFP Technologies (NASDAQ:UFPT), recently sold 10,682 shares for $3.40 million, reducing his stake by 37.21%, and an additional 5,013 shares for $1.59 million. Despite these sales, UFP Technologies stock rose to $325, near its 52-week high, following a strong earnings report where quarterly EPS and revenue exceeded analyst estimates. The company currently holds an average "Hold" rating from analysts, though some have recently upgraded it to "Buy."
UFP Technologies (NASDAQ:UFPT) Chairman Sells 5,013 Shares of Stock
UFP Technologies (NASDAQ:UFPT) Chairman R. Jeffrey Bailly sold 5,013 shares of the company's stock on August 7th, 2026, for approximately $1.59 million, reducing his direct ownership by 27.81%. This follows another sale of 10,682 shares on August 6th. The company's stock traded near its 52-week high at $325, with a market capitalization of $2.51 billion, and recently beat quarterly earnings estimates.
Why UFP Technologies (UFPT) Is Up 23.2% After Stronger Q2 2026 Revenue And Earnings Performance
UFP Technologies (UFPT) saw its stock rise by 23.2% following a strong Q2 2026 performance, with reported sales of US$173.96 million and net income of US$20.85 million. The company's first-half 2026 results also indicate increased profitability, driven by higher sales and earnings, supporting its strategy of margin improvement and growth through acquisitions. While analysts project significant revenue and earnings growth by 2029, customer concentration remains a key risk.
The Top 5 Analyst Questions From UFP Technologies’s Q2 Earnings Call
UFP Technologies (UFPT) reported strong Q2 2026 earnings, exceeding Wall Street expectations with robust growth driven by its MedTech platform, particularly in cardiovascular, infection control, and orthopedics. CEO Mitchell Rock highlighted diversified growth across multiple medical end markets and operational benefits from capacity investments. Analysts focused on growth drivers, sustainability of SG&A, acquisition pipeline, resolution of backlog/labor issues, and new program ramp-ups outside top customers.
Why UFP Technologies (UFPT) Is Up 23.2% After Stronger Q2 2026 Revenue And Earnings Performance
UFP Technologies (UFPT) reported strong Q2 2026 results with sales of US$173.96 million and net income of US$20.85 million, leading to a 23.2% stock increase. The company's first-half performance shows increased profitability and sales, supporting its investment narrative focused on operational efficiency and strategic acquisitions. While the stronger earnings provide flexibility for acquisitions, investor awareness of customer concentration risk remains crucial.
UFP Technologies (UFPT) Vice President Jason Holt Sells 1,100 Sh
UFP Technologies (UFPT) Vice President Jason Holt sold 1,100 shares of the company stock for approximately $348,700, bringing his direct ownership to 7,878 shares. This sale contributes to a pattern of insider selling over the past year, with 0 buys and 6 sells, indicating a potentially cautious sentiment from insiders. The stock is currently considered "Modestly Overvalued" based on its GF Value, trading at a premium price-earnings ratio compared to industry and historical averages.
Royal Bank of Canada Decreases Stake in UFP Technologies, Inc. $UFPT
Royal Bank of Canada reduced its stake in UFP Technologies (NASDAQ:UFPT) by 12.5% in the first quarter, selling 11,343 shares and retaining 79,179 shares valued at $15.3 million. Despite this, UFP Technologies reported strong quarterly earnings of $2.92 EPS and revenue of $173.96 million, both exceeding analyst expectations. Institutional investors collectively own 87.28% of the company, and the stock currently holds an average analyst rating of "Hold."
Janus Henderson Group PLC Has $3.76 Million Stock Holdings in UFP Technologies, Inc. $UFPT
Janus Henderson Group PLC significantly reduced its stake in UFP Technologies, Inc. (NASDAQ:UFPT) by 75.5% in the first quarter, now holding 19,436 shares valued at $3.76 million. Despite this, other institutional investors have increased their holdings, with institutional investors collectively owning 87.28% of the company. UFP Technologies reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, with shares trading near their 52-week high.
UFP Technologies (NASDAQ:UFPT) Upgraded to Buy at Wall Street Zen
UFP Technologies (NASDAQ:UFPT) was upgraded to a "Buy" rating by Wall Street Zen, though its overall analyst rating remains "Hold" due to Weiss Ratings only slightly increasing its score. The company recently reported strong quarterly earnings, beating both EPS and revenue estimates. Despite recent stock sales by two directors, institutional investors hold a significant 87.28% of outstanding shares.
Earnings Beat: UFP Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
UFP Technologies, Inc. (NASDAQ:UFPT) surpassed analyst expectations in its second-quarter results, with revenues reaching US$174m and statutory earnings per share exceeding predictions by 16%. Following these strong results, analysts have upgraded their revenue and EPS forecasts for 2026 and increased their price target to US$355 per share, reflecting a moderate uplift in sentiment. While revenue growth is expected to slow compared to historical performance, it is still projected to align with the industry average.
UFP Technologies Q2 2026: Revenue $173.96M, EPS $2.68— 10-Q Summary
UFP Technologies reported strong second-quarter 2026 results with revenue of $173.96 million and diluted EPS of $2.68, showing significant year-over-year growth. The company's financial performance was driven by a 15.1% YoY increase in revenue and a 21.3% YoY rise in net income and EPS, attributed to growth in specific medical sectors and operational efficiencies. Despite relying on two major customers and addressing post-acquisition labor challenges and a recent cyber incident, UFP Technologies saw improved gross margins and is actively restoring workforce capacity.
UFP Technologies (NASDAQ: UFPT) grows Q2 2026 sales and earnings
UFP Technologies reported strong financial results for Q2 2026, with net sales increasing by 15.1% to $174.0 million and diluted EPS reaching $2.68. The growth was primarily driven by its medical sub-markets, leading to an improved gross margin of 29.3%. Despite these gains, the company experienced a decrease in operating cash flow due to higher receivables and inventories, and continues to manage customer concentration risks and operational disruptions at its AJR subsidiary.
UFP TECHNOLOGIES INC SEC Filing (Aug 6, 2026)
UFP Technologies Inc. (UFPT) filed a Form 144 with the SEC on August 6, 2026, indicating a proposed sale of 1100 shares of common stock by an unnamed individual. The shares, acquired via a stock award from the issuer on March 3, 2025, have an aggregate market value of $348,700 and are intended to be sold on Nasdaq through Merrill Lynch. The filing confirms the transaction's details, including acquisition date, method, and payment type.
UFP Technologies (UFPT) VP sells 1,100 shares at $317
UFP Technologies Vice President Jason Holt sold 1,100 shares of the company's common stock at $317 per share on August 6, 2026. This open market transaction totaled $349,000. Following the sale, Holt directly owns 7,878 shares of UFPT common stock.
Earnings Beat: UFP Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
UFP Technologies, Inc. (NASDAQ:UFPT) surpassed analyst expectations for its second-quarter results, with revenues reaching US$174m and statutory earnings per share exceeding predictions by 16%. Following these strong results, analysts have updated their forecasts, moderately increasing revenue and EPS predictions for 2026 and raising the consensus price target to US$355 per share. While revenue growth is expected to slow compared to historical performance, it is still projected to align with the industry average.
